U.S. market Closed. Opens in 9 hours 40 minutes

NBIX | Neurocrine Biosciences, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for NBIX we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is moderate, Growth is exceptionally good and Health is confidently strong.

Valuation (36%)

Company Industry
P/E Ratio (TTM) 34.50 16.83
PEG Ratio (TTM) -3.81 -22.40
P/S Ratio (TTM) 5.53 5.41
P/B Ratio (TTM) 4.66 4.28
P/FCF Ratio (TTM) 23.70 8.05
Price to 5YR AVG Earnings Ratio 58.66 28.12
Price to 5YR AVG FCF Ratio 46.06 20.99

Profitability (60%)

Company Industry
ROA (TTM) 10.26% 2.55%
ROE (TTM) 14.86% 16.58%
Net Profit Margin (TTM) 16.00% -13.15%
ROIC 5YR AVG 16.80% 9.71%

Growth (92%)

4QTR AVG 3YR AVG 5YR AVG
EPS 10.18% 329.38% 223.33%
Revenue 7.01% 38.58% 34.77%
Net Income 10.98% 332.69% 226.43%
Cash Flow -17.16% 37.51% 31.95%

Health (81%)

Company Industry
Current Ratio (TTM) 4.19 2.49
Quick Ratio (TTM) 4.08 1.85
D/E Ratio (TTM) 0.12 -0.31
Interest Coverage (TTM) 165.06 11.90
Piotroski F-Score 4 6
Altman Z-Score 10.37 4.64
LTL to 5YR AVG FCF 1.01 4.62
Shares Outstanding Growth 5YR AVG 1.61% 30.07%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙